Increased Serum Level of MicroRNA-663 Is Correlated with Poor Prognosis of Patients with Nasopharyngeal Carcinoma

Abstract EN

MicroRNAs (miRs) play crucial roles in the carcinogenesis and malignant progression of human cancers including nasopharyngeal carcinoma (NPC).

In this study, we aimed to investigate the association of serum miR-663 levels with the clinical factors and prognosis of NPC patients.

Real-time PCR was performed to examine the amount of miR-663 in serum in NPC patients and healthy controls.

Our data showed that the amount of miR-663 in serum was significantly higher in NPC patients than in healthy controls.

Moreover, the serum levels of miR-663 were significantly correlated with the grade, lymph node metastasis, and clinical stage of NPC.

Furthermore, higher serum miR-663 levels were closely associated with worse 5-year overall survival (OS) and relapse-free survival (RFS) of patients with NPC, and the serum level of miR-663 was found to be an independent predicator for the prognosis of NPC.

In addition, after receiving chemoradiotherapy, the serum levels of miR-663 were significantly reduced in NPC patients.

In summary, miR-663 was upregulated in the serum of NPC patients, which was downregulated after chemoradiotherapy, and its increased levels were closely associated with malignant progression and poor prognosis in NPC patients.

Therefore, the amount of miR-663 in serum may become a potential predicator for the clinical outcome of NPC patients.